Reaction
Angiosarcoma reporting signals
As of the last recalculation, Angiosarcoma appears in 459 FAERS reports alongside 8 co-occurring drug terms. The strongest observed disproportionality signal is PAZOPANIB HYDROCHLORIDE (PRR 75.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Pazopanib Hydrochloride | 41 | 75.3 | 75.5 |
| Mycophenilic Acid | 23 | 52.9 | 53.0 |
| Everolimus Tablets | 16 | 44.8 | 44.8 |
| Tacrolimus Ointment 0.1% | 96 | 43.9 | 44.0 |
| Tacrolimus Extended-Release Capsules | 96 | 43.8 | 43.9 |
| Tacrolimus | 99 | 36.3 | 36.3 |
| Mycophenolic Acid | 23 | 34.3 | 34.3 |
| Ifosfamide | 9 | 19.4 | 19.4 |